Insights on Voting Rights and Share Capital Structure
Understanding Voting Rights and Share Capital at Biotalys
Biotalys NV, a dynamic player in the Agricultural Technology (AgTech) sector, is committed to revolutionizing crop protection through innovative biocontrol solutions. Let's delve into important details regarding the company's share capital and voting rights that reflect its increasing influence and evolution within the agricultural landscape.
Key Financial Figures of Biotalys
As of the latest report, Biotalys holds a share capital of EUR 5,547,787.68. With a remarkable total of 37,518,645 securities carrying voting rights, all of which pertain to ordinary shares, the company presents a robust framework for shareholder engagement.
Additional Securities and Voting Rights
The company also has several outstanding rights for subscribing to securities that carry voting rights. Notably, there are:
- 1,879,400 “ESOP Warrants” that allow holders to subscribe to a maximum of 939,700 ordinary shares.
- 1,382,678 additional “ESOP Warrants” that provide rights for more securities.
- 28,653 share units allocated to independent directors, mandating them to acquire new shares at a symbolic price of one EUR each, with possible cash settlement options.
It is worth noting that Biotalys has no outstanding convertible bonds or non-voting shares, emphasizing the clear structure of their equity instruments.
Recent Changes to Capital Structure
Biotalys' share structure witnessed changes due to the recent issuance of 42,500 shares tied to incentive plans for staff, alongside the issuance of 6,083 shares linked to the remuneration policy for independent directors. These strategic steps underscore the company's commitment to both enhancing its workforce's engagement and rewarding its leadership.
Report Availability
In compliance with legal regulations, detailed reports from the board of directors and auditors regarding the issuance of new shares are accessible on the company's website, providing transparency and accountability to its investors.
Regulatory Compliance and Shareholder Notification
Biotalys upholds strong adherence to the Belgian Act requiring notifications from any individuals or entities whose voting rights in the company breach certain thresholds. This ensures that significant changes in shareholding positions are always communicated to both the company and regulatory bodies.
Contact Information
For further inquiries or clarifications regarding share capital or voting rights, interested parties are encouraged to reach out to Toon Musschoot, Head of Investor Relations and Communication, via phone at +32 (0)9 274 54 00 or email at IR@biotalys.com.
About Biotalys and Its Innovations
Biotalys is dedicated to offering sustainable alternatives to chemical pesticides, aiming for a safer and more responsible food supply. The company utilizes its AGROBODY™ technology platform to craft a diverse pipeline of effective products designed to counteract common crop pests and diseases throughout the agricultural production cycle. Established as a spin-off from the VIB (Flanders Institute for Biotechnology) in 2013, it has made significant strides in securing its position within the biotech cluster in Ghent, Belgium, and has been listed on Euronext Brussels since July 2021.
Frequently Asked Questions
What is the share capital of Biotalys?
The share capital of Biotalys is EUR 5,547,787.68.
How many voting rights does Biotalys have?
Biotalys has a total of 37,518,645 voting rights, all relating to ordinary shares.
What are ESOP Warrants?
ESOP Warrants are rights that allow holders to subscribe to shares at specific prices, incentivizing employee retention and performance.
Are there any non-voting shares at Biotalys?
No, Biotalys does not have any outstanding non-voting shares or convertible bonds.
Who can I contact for more information?
For inquiries, contact Toon Musschoot at +32 (0)9 274 54 00 or via email at IR@biotalys.com.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
